Rethinking the benefits of digital adherence technologies for tuberculosis treatment. Marx FM, Civan A. Lancet 2025 Mar 11:S0140-6736(25)00199-0. doi: 10.1016/S0140-6736(25)00199.

Read + Share

Amedeo Smart

Independent Medical Education

Marx FM, Civan A. Rethinking the benefits of digital adherence technologies for tuberculosis treatment. Lancet 2025 Mar 11:S0140-6736(25)00199-0. doi: 10.1016/S0140-6736(25)00199.
PMID: 40086456